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ABSTRACT
Recent studies have revealed an important role for LTBP-4 in
elastogenesis. Its mutational inactivation in humans causes
autosomal recessive cutis laxa type 1C (ARCL1C), which is a
severe disorder caused by defects of the elastic fiber network.
Although the human gene involved in ARCL1C has been
discovered based on similar elastic fiber abnormalities exhibited by
mice lacking the short Ltbp-4 isoform (Ltbp4S−/−), the murine
phenotype does not replicate ARCL1C. We therefore inactivated
both Ltbp-4 isoforms in the mouse germline to model ARCL1C.
Comparative analysis of Ltbp4S−/− and Ltbp4-null (Ltbp4−/−) mice
identified Ltbp-4L as an important factor for elastogenesis and
postnatal survival, and showed that it has distinct tissue expression
patterns and specific molecular functions. We identified fibulin-4 as
a previously unknown interaction partner of both Ltbp-4 isoforms
and demonstrated that at least Ltbp-4L expression is essential for
incorporation of fibulin-4 into the extracellular matrix (ECM). Overall,
our results contribute to the current understanding of elastogenesis
and provide an animal model of ARCL1C.
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INTRODUCTION
The extracellular matrix (ECM) determines and controls the
biochemical and mechanical properties of all mammalian tissues
including specific ligand-binding properties, elasticity and stiffness
(Frantz et al., 2010). As integral ECM components, elastic fibers
enable elastic recoil and resilience in all elastic tissues such as
arteries, lung, skin and cartilage. Despite being indispensable for
survival and normal tissue function (Hornstra et al., 2003; Li et al.,
1998), the molecular mechanisms controlling elastic fiber formation
have only recently been investigated in more detail (Choudhury et
al., 2009; Dabovic et al., 2015; Hirai et al., 2007; Horiguchi et al.,
2009; Noda et al., 2013; Sideek et al., 2014). Elastic fibers consist
of an internal core of cross-linked monomeric elastin (tropoelastin)
surrounded by a network of fibrillin-rich microfibrils (Kielty et al.,
2002; Mithieux and Weiss, 2005). Elastic fiber formation in the
ECM is a complex process, which involves the formation of
fibrillin-rich microfibrillar scaffolds and the deposition of the
tropoelastin molecules onto these scaffolds. These processes are
followed by the cross-linking of tropoelastin after oxidative
deamination of lysine residues by enzymes of the lysyl oxidase
family, leading to the formation of covalent cross-links such as
desmosines and isodesmosines (Mithieux and Weiss, 2005;
Wagenseil and Mecham, 2007; Yanagisawa and Davis, 2010). This
process is strongly influenced by the composition of the
microfibrillar scaffold. Although the role of several microfibrillar
proteins in elastic fiber formation has been studied in more detail
(Mithieux and Weiss, 2005; Ramirez et al., 2004; Todorovic and
Rifkin, 2012), the impact of the microfibril-associated latent
transforming growth factor β-binding protein 4 (LTBP-4) on elastic
fiber formation is still poorly understood.
LTBP-4 belongs to a family of four (LTBP-1–LTBP-4) secreted
ECM glycoproteins with structural homology to fibrillins (fibrillin-
1–fibrillin-3). LTBP-1, LTBP-3 and LTBP-4 covalently bind the
small latent complex (SLC) of TGFβ (TGFβ-LAP; LAP, latency-
associated peptide) and deposit these complexes into the ECM after
secretion (Todorovic and Rifkin, 2012). LTBP-1 and LTBP-3 bind
all three TGFβ isoforms, whereas LTBP-4 binds only TGFβ1
(Saharinen et al., 1998). In addition to a TGFβ-related function,
LTBPs have structural functions within the ECM (Isogai et al.,
2003). For example, LTBP-2, a non TGFβ carrier, interacts with
fibulin-5 and thus negatively regulates elastogenesis (Sideek et al.,
2014), whereas LTBP-4 facilitates elastogenesis by interacting with
fibulin-5 (Dabovic et al., 2015; Noda et al., 2013).
Mammalian cells express two major isoforms of LTBP-4, which in
analogy to the long and short isoforms of LTBP-1 discovered earlier
are also called long (LTBP-4L; human: NM_001042544.1; murine:
NM_175641.2) and short (LTBP-4S; human, NM_001042545.1;
murine, NM_001113549.1). These isoforms are encoded by two N-
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terminal splice variants that are independently expressed using their
own promoters (Kantola et al., 2010). In humans LTBP-4L and
LTBP-4S are differentially expressed in a tissue-specific manner and
show distinct deposition patterns in the ECM (Kantola et al., 2010),
presumably due to their different N-termini. For ECM-targeting, the
N-terminus of LTBP-4 appears to be particularly important because it
enables binding to fibronectin and thereby guides LTBP-4 deposition
into the early ECM (Kantola et al., 2008).
We and others have previously reported that mice with an
inactivating mutation of Ltbp4S (Ltbp4S−/− mice) are born with
alveolar septation defects that deteriorate with age and eventually
develop massive pulmonary emphysema associated with dilated
cardiomyopathy (Dabovic et al., 2009; Sterner-Kock et al., 2002).
In humans, null mutations in the LTBP4 gene cause autosomal
recessive cutis laxa type 1C (ARCL1C; initially called Urban-
Rifkin-Davis syndrome), which is a rare congenital connective
tissue disorder characterized by severe craniofacial anomalies, lax
skin and severe abnormalities in several visceral organs including
the lung. However, ARCL1C patients have several lesions that have
not been described in Ltbp4S−/− mice (Callewaert et al., 2013;
Sterner-Kock et al., 2002; Urban et al., 2009). A possible
explanation for this could be that Ltbp-4L expressed in Ltbp4S−/−
mice compensates in part for the loss of Ltbp-4S.
To address Ltbp-4 isoform-specific functions, we generated
Ltbp4-null (Ltbp4−/−) mice that, like the ARCL1C patients, do not
express any Ltbp-4. Here, we show that Ltbp4−/− mice nearly
replicate the features of ARCL1C syndrome. We further show that
Ltbp-4L and Ltbp-4S have important and partially non-overlapping
roles in survival and elastic fiber formation, identify fibulin-4 as a
new interacting partner of both Ltbp-4 isoforms and demonstrate
that at least Ltbp-4L expression is essential for incorporation of
fibulin-4 into the ECM.
RESULTS
Complete inactivation of the Ltbp4 gene in mice results in
weight loss, growth reduction and neonatal death
We previously established and characterized Ltbp4S-knockout
(Ltbp4S−/−) mice (Sterner-Kock et al., 2002), which show similar
elastic fiber defects in the lung to those found in ARCL1C patients;
however the mice survived to adulthood without manifestation of
major clinical symptoms. To investigate whether the less-severe
phenotype of Ltbp4S−/− mice was due to the presence of Ltbp-4L,
which might have important functions during development, we
generated Ltbp4-null (Ltbp4−/−) mice lacking both Ltbp-4 isoforms
(supplementary material Fig. S1). Indeed, unlike Ltbp4S−/− mice,
Ltbp4−/− mice showed no expression of Ltbp-4 (Fig. 1A;
supplementary material Fig. S2).
Complete lack of Ltbp-4 expression reduced survival dramatically
as most Ltbp4−/−mice died between P8 and P14 (Fig. 1B), whereas
Ltbp4S−/− mice survived to adulthood (Sterner-Kock et al., 2002).
Furthermore, Ltbp4−/− mice were smaller than Ltbp4S−/− mice and
showed decreased body weight as compared with their wild-type
(WT) littermates (Fig. 1C,D; Table 1).
Ltbp-4-deficient mice show morphological abnormalities in
lung, aorta and skin
Similar to the ARCL1C lung histopathology, the lungs of Ltbp4−/−
mice lacked a lobular architecture and showed severely enlarged
alveolar spaces (Fig. 1E). Lungs from Ltbp4S−/− mice also exhibited
enlarged alveolar spaces with multifocal areas of atelectasis although
these were much less pronounced than in the Ltbp4−/− lungs
(Fig. 1E). This difference was reflected by a significantly reduced
oxygen saturation (sO2) and partial oxygen pressure (pO2) in
Ltbp4−/− mice when compared with Ltbp4S−/− and WT mice
(Table 1).
Aortas of Ltbp-4-deficient mice were malformed and tortuous
(supplementary material Fig. S3) (Noda et al., 2013). Aortic walls
were twice as thick in Ltbp4−/− mice as in WT mice (Fig. 1F,G). The
aortic wall thickening could not be attributed to extra elastic
lamellae (Fig. 1F), increased deposition of glycosaminoglycans in
the ECM, increased numbers of smooth muscle cells or increased
proliferation (supplementary material Fig. S4).
Ltbp4−/− mice showed reduced dermal thickness compared to
Ltbp4S−/− and WT mice (Fig. 1H,I), whereas the thickness of the
epidermis was not changed (data not shown). The epidermal
hydration was increased (Fig. 1J) and the transepidermal water loss
(Fig. 1K) tended to be higher but did not reach statistical
significance in Ltbp4−/− mice compared to Ltbp4S−/− and WT mice.
The net-elasticity of the skin of both Ltbp-4-deficient mice tended
to be lower but did not reach statistical significance compared to
WT mice (Fig. 1L).
Ltbp4−/− mice develop cardiac hypertrophy of the right
ventricle with flattening of the interventricular septum
Hearts of Ltbp4−/− but not of Ltbp4S−/− mice were larger when
compared to WT hearts (Fig. 1M) as indicated by higher heart to body
weight (Fig. 1N) and heart weight to tibia length ratios (Table 1).
Stereological analysis revealed significantly increased right ventricular
wall thickness in Ltbp4−/− hearts as compared to Ltbp4S−/− or WT
hearts, but showed no change in the left ventricular walls (Fig. 1O,P).
The left ventricular end-diastolic volume (LVEDV), the left
ventricular end-systolic volume (LVESV) and the stroke volume (SV)
tended to be lower and the ejection fraction (EF) tended to be higher
but did not reach statistical significance in Ltbp4−/− mice compared to
WT mice (supplementary material Table S1).
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TRANSLATIONAL IMPACT
Clinical issue
Recent studies revealed an important role for latent TGFβ-binding
protein-4 (LTBP-4) in elastogenesis (formation of elastic fibers). Its
mutational inactivation in humans causes autosomal recessive cutis laxa
type 1C (ARCL1C), which is a severe disorder caused by defects of the
elastic fiber network. Although the human gene involved in ARCL1C was
discovered based on similar elastic fiber abnormalities exhibited by
Ltbp4S–/– mice (which lack the short Ltbp-4 isoform), the murine
phenotype does not replicate human ARCL1C. The authors therefore
hypothesize that inactivation of both the long (Ltbp-4L) and short
Ltbp-4 isoforms in the mouse germline might model ARCL1C.
Results
Comparative analysis of Ltbp4S–/– and Ltbp4-null (Ltbp4–/–) mice identify
important and partially non-overlapping functions of Ltbp-4L and Ltbp-4S
in survival and elastic fiber formation, as well as unique and overlapping
expression of the two isoforms depending on the analyzed tissue, with
characteristic tissue localization patterns. Furthermore, the authors
identify fibulin-4 as a new interaction partner of both Ltbp-4 
isoforms and demonstrate that Ltbp-4L is crucial for postnatal survival.
Moreover, the authors show that specific N-glycosylation of Ltbp-4S
modulates its binding affinity to fibulin-4- and fibulin-5.
Implications and future directions 
Overall, the results contribute to the current understanding of elastogenesis
and provide an animal model of ARCL1C. The study documents that Ltbp-
4L and Ltbp-4S have distinct roles in elastic fiber formation and postnatal
survival in mice and identify fibulin-4 as an interaction partner of both Ltbp-
4 isoforms. Future experiments involving the generation of Ltbp4L-
knockout and tissue-specific-Ltbp4-knockout mouse lines are planned to
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Fig. 1. Clinical and morphological analyses of Ltbp-4 deficient mice. (A) Representative immunoblots of lung, aorta, skin and hearts showing the reduced
or absent expression of Ltbp-4 in Ltbp4S−/− and Ltbp4−/− mice compared to WT mice. (B) Kaplan–Meier survival curve revealing the significantly higher
neonatal mortality in Ltbp4−/− mice compared to Ltbp4S−/− and WT mice (n≥23; **P<0.01 versus WT). (C) Ltbp4−/− mice showed reduced body size compared to
Ltbp4S−/− and WT mice. Scale bar: 0.5 cm. (D) The P4-P12 weight curve showed significantly reduced body weight of Ltbp4−/− mice compared to Ltbp4S−/− and
WT mice (n≥8; **P<0.01 versus WT). (E) In Ltbp4S−/− mice, the pulmonary parenchyma showed enlarged alveolar spaces with reduced numbers of alveoli and
multifocal areas of atelectasis compared to WT mice. Ltbp4−/− lungs revealed lack of lobular architecture, severely enlarged alveolar spaces and
emphysematous areas compared to WT mice. Scale bars: 40 μm. (F,G) Aortas showed marked thickening of the aortic wall in Ltbp4S−/− and Ltbp4−/− mice
compared to WT mice (n≥3; *P<0.05, **P<0.01). Scale bars: 40 μm. (H,I) Ltbp4−/− mice showed reduced dermal thickness compared to Ltbp4S−/− and WT mice
(n≥5;**P<0.01). Scale bars: 200 μm. (J) The epidermal hydration was increased in Ltbp4−/− mice compared to Ltbp4S−/− and WT mice (n≥9; *P<0.05). (K) The
transepidermal water loss tended to be higher in Ltbp4−/− mice compared to Ltbp4S−/− and WT mice (n≥9; not significant). (L) The net-elasticity of the skin of
both Ltbp-4-deficient mice tended to be lower compared to WT mice (n≥9; not significant). (M) Representative images showing the increased size of hearts of
Ltbp4−/− mice compared to hearts of WT and Ltbp4S−/− mice. Scale bar: 0.1 cm. (N) Heart weight:body weight ratios showing that hearts of Ltbp4−/− mice were
significantly heavier than hearts of WT and Ltbp4S−/− mice (n≥7; **P<0.01). (O) Wall thickness of the left ventricle was not changed in Ltbp4S−/− and Ltbp4−/−
mice compared to WT mice (n≥6; not significant). (P) Wall thickness of the right ventricle was significantly increased in Ltbp4−/− mice compared to Ltbp4S−/−
and WT mice (n≥6; *P<0.05). (Q) Representative short-axis images from MRI analysis revealing a flattened interventricular septum resulting in a more oval
















Ltbp4−/− mice and to a lesser extent Ltbp4S−/− mice develop
flattened interventricular septae resulting in a more oval shape of the
left ventricle on short axis views (Fig. 1Q). The ratio between the
maximum and minimum diameter of the left ventricle measured on
end-diastolic short axis images was 1.5 in Ltbp4−/− and 1.4 in
Ltbp4S−/− mice. In contrast, the ratio for WT ventricles was 1.1,
consistent with a round ventricle shape (Fig. 1Q).
Overlapping and distinct expression and localization
patterns of Ltbp-4L and Ltbp-4S
Because the different phenotypes of Ltbp4S−/− and Ltbp4−/− mice
might reflect differences in tissue-specific expression and
localization of the Ltbp-4 isoforms, we quantified the amount of
Ltbp4L and Ltbp4S transcripts in various tissues of WT, Ltbp4S−/−
and Ltbp4−/− mice and related these results to Ltbp-4 protein
expression.
WT lungs expressed comparable amounts of Ltbp4L and Ltbp4S
mRNA, whereas in lungs from Ltbp4S−/− mice only Ltbp4L was
expressed. In the lungs of Ltbp4−/− mice neither Ltbp4L nor Ltbp4S
mRNA was expressed (Fig. 2A,B). Ltbp-4 immunoreactivity was
found primarily in the bronchial and bronchiolar walls, as well as in
the parenchyma and vascular walls, of WT lungs (Fig. 2C). There
was no difference in the tissue distribution of Ltbp-4 between WT
and Ltbp4S−/− lungs (Fig. 2C), indicating that Ltbp-4 isoform
expression is overlapping in the lung. Ltbp-4 immunoreactivity was
completely absent in Ltbp4−/− lungs (Fig. 2C).
Aortas of WT mice expressed comparable amounts of Ltbp4L and
Ltbp4S mRNA, whereas the aortas of Ltbp4S−/− mice expressed
exclusively Ltbp4L mRNA. Aortas of Ltbp4−/− mice expressed
neither Ltbp4 isoform (Fig. 2A,B). In WT aortas, Ltbp-4
immunoreactivity was present in the vicinity of the aortic elastic
lamellae throughout the entire aortic wall extending from the
endothelial lining to the adventitia (Fig. 2D). However, in Ltbp4S−/−
mice, Ltbp-4 was only detectable in the vicinity of the internal
elastic lamella (IEL) and in the adventitia. Intramural elastic
lamellae of Ltbp4S−/− mice were negative for Ltbp-4 staining,
suggesting that Ltbp-4L expression is restricted to the adventitia and
the IEL (Fig. 2D). Aortas of Ltbp4−/− mice expressed no Ltbp-4
(Fig. 2D).
In WT skin, Ltbp4S was the major isoform expressed,
representing about 98% of the total Ltbp4 transcripts. In Ltbp4S−/−
skin, only Ltbp4L mRNA was expressed and in Ltbp4−/− skin neither
Ltbp4L nor Ltbp4S mRNA was expressed (Fig. 2A,B). In WT skin,
Ltbp-4 immunoreactivity was present in the entire dermis and was
completely absent in the epidermis (Fig. 2E). There was no
difference in the tissue distribution of Ltbp-4 between WT and
Ltbp4S−/− skin (Fig. 2E), indicating that Ltbp-4 isoform expression
is overlapping in the skin. The skin of Ltbp4−/− mice expressed no
Ltbp-4 (Fig. 2E).
Ltbp4S was the major isoform expressed in WT hearts,
representing about 93% of the total Ltbp4 transcripts. Hearts of
Ltbp4S−/− mice expressed only Ltbp4L mRNA. Ltbp4−/− hearts
expressed neither Ltbp4L nor Ltbp4S mRNA (Fig. 2A,B). In the
heart, Ltbp-4 immunoreactivity was detectable in the epicardium,
myocardium and endocardium of WT mice (Fig. 2F). In Ltbp4S−/−
hearts Ltbp-4 immunoreactivity was only detectable in the
endocardium, implying that Ltbp-4L expression is restricted to this
region. Ltbp4−/− hearts showed no Ltbp-4 immunoreactivity (Fig.
2F).
Ltbp-4 deficiency in mice results in the failure to form an
intact elastic fiber network
We and others have shown that Ltbp4S−/− mice display severe
defects in elastic fiber formation (Dabovic et al., 2015; Noda et al.,
2013; Sterner-Kock et al., 2002; Urban et al., 2009). Elastic fiber
fragmentation was present in aortas and lungs of both Ltbp-4-
deficient mice (Fig. 2G). In Ltbp4S−/− mice, elastic fibers, although
fragmented, consisted of short intact fibers dispersed between
scattered patches of elastin. In contrast, Ltbp4−/− tissues showed only
scattered patches of elastin (Fig. 2G). These observations were
confirmed on ultrastructural images of semi-thin sections (Fig. 2H,
supplementary material Fig. S5A).
Major differences in elastic fiber structure between the Ltbp-4-
deficient mice were found in the subluminal region of the aorta,
where Ltbp-4L is preferentially expressed (Fig. 2D). Whereas
Ltbp4S−/− aortas exhibited only moderate disruptions of the IEL
adjacent to the endothelial lining, disruptions were significantly
more severe in the aortas of Ltbp4−/− mice (Fig. 2I).
There were no significant differences in tropoelastin mRNA
expression (supplementary material Fig. S5B), in the amount of
elastin (supplementary material Fig. S5C) or in the ratio of
desmosine (DES) and isodesmosine (IDES) to elastin
(supplementary material Fig. S5D) between the genotypes,
indicating that the elastic fiber defects observed in the Ltbp-4-
deficient mice were not due to altered elastin levels or ineffective
elastin cross-linking.
Ltbp-4 modulates fibulin-5 expression and matrix deposition
It has been suggested that Ltbp-4S promotes elastic fiber assembly
by facilitating tropoelastin deposition onto microfibrils through
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Table 1. Body weight, tibia length, heart weight:tibia length ratios and blood gas analyses from trunk blood of WT, Ltbp4S−/− and Ltbp4−/−
mice
WT (n≥19) Ltbp4S−/− (n≥8) Ltbp4−/− (n≥13)
Body weight (g) 4.776±0.9029 4.496±0.5905 4.415±0.7561
Tibia length (mm) 6.718±0.0595* 6.536±0.0369 6.422±0.0384
Heart weight:tibia length 4.532±0.8376** 4.902±0.7066 6.149±1.9658
pH 7.45±0.05 7.44±0.04 7.42±0.056
pCO2 (mmHg) 40.70±6.70 42.85±3.98 40.74±5.23
pO2 (mmHg) 38.11±5.36* 42.14±6.52** 33.37±2.89
sO2 (%) 62.93±13.72** 67.21±14.67** 48.39±9.70
ctHb (g/dl) 9.31±1.04 8.65±0.48 9.19±0.82
Hct (%) 28.81±3.08 26.89±1.46 28.96±1.27
HCO3 (mmol/l) 27.79±2.56 28.39±3.03 27.33±2.74
ABE (mmol/l) 3.98±2.37 4.21±2.18 3.35±2.79
Body weight, tibia length, heart weight:tibia length ratios and blood gas analysis of mixed trunk blood from WT, Ltbp4S−/− and Ltbp4−/− mice at P9. Data were
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Fig. 2. Localization patterns of Ltbp-4L, Ltbp-4S and elastin. (A) Quantitative PCRs of lung, aorta, skin and heart of WT and Ltbp4S−/− mice showing that
each tissue had different amounts of Ltbp4L mRNA. There was no mRNA expression of Ltbp4L in lung, aorta, skin and heart of Ltbp4−/− mice (n≥3; §, no
expression detectable). (B) Quantitative PCRs of lung, aorta, skin and heart of WT mice showing that each tissue had different amounts of Ltbp4S mRNA.
There was no mRNA expression of Ltbp4S in lung, aorta, skin and heart of Ltbp4S−/− and Ltbp4−/− mice (n≥3; §, no expression detectable). (C) Representative
images of Ltbp-4 immunoreactivity of lungs from WT, Ltbp4S−/− and Ltbp4−/− mice. Ltbp-4 was localized particularly in bronchial and bronchiolar walls and in
vascular walls of WT and Ltbp4S−/− mice. Lungs of Ltbp4−/− mice were negative for Ltbp-4 immunoreactivity. Scale bars: 20 μm. (D) Representative images of
Ltbp-4 immunoreactivity of aortas from WT, Ltbp4S−/− and Ltbp4−/− mice. Black arrows point to the aortic luminal side and black arrowheads to the adventitia.
Ltbp-4 immunoreactivity was present in the vicinity of aortic elastic lamella throughout the entire aorta (from the endothelial lining to the adventitia) of WT mice
and in the vicinity of the internal elastic lamella (IEL) and in the adventitia of Ltbp4S−/− mice. The aortic intramural elastic lamella of Ltbp4S−/− mice and the
entire aorta of Ltbp4−/− mice showed no immunoreactivity for Ltbp-4. Scale bars: 20 μm. (E) Representative images of Ltbp-4 immunoreactivity of skin from WT,
Ltbp4S−/− and Ltbp4−/− mice. In WT skin, Ltbp-4 immunoreactivity was present in the entire dermis, whereas it was completely absent in the epidermis. There
was no difference in the tissue distribution of Ltbp-4 between WT and Ltbp4S−/− skin. The skin of Ltbp4−/− mice expressed no Ltbp-4. Scale bars: 20 μm.
(F) Representative images of Ltbp-4 immunoreactivity of hearts from WT, Ltbp4S−/− and Ltbp4−/− mice. Upper panel: black arrows point to the epicardium of the
heart. Ltbp-4 immunoreactivity was present within the myocardium and in the epicardium of WT mice. The myocardium and the epicardium of Ltbp4S−/− and
Ltbp4−/− mice were negative for Ltbp-4 immunoreactivity. Lower panel: black arrows point to the endocardium. The endocardium of WT and Ltbp4S−/− mice
clearly has Ltbp-4 immunoreactivity, whereas Ltbp4−/− mice were negative for Ltbp-4 immunoreactivity. Scale bars: 20 μm. (G) Representative histochemical
elastica stainings of lungs (upper panels) and aortas (lower panels) displaying moderate elastic fiber fragmentation with intact and disrupted elastic fibers in
Lbp4S−/− mice compared to WT mice and an increased degree of fragmentation of the elastic fibers in Ltbp4−/− mice compared to Lbp4S−/− mice. Scale bars: 20
μm. (H) Representative semi-thin sections of lungs showing elastic fibers with fragmented and intact parts in Lbp4S−/− mice and total disruption of elastic fibers
in Ltbp4−/− mice compared to WT mice. Scale bars: 6 μm. (I) Quantitative analysis of disruptions of the IEL showing significantly higher numbers of disruptions
in Ltbp4−/− mice compared to WT and Ltbp4S−/− mice and significantly higher numbers of disruptions in Ltbp4S−/− mice compared to WT mice (n=6; n.d., not
















direct interactions with fibulin-5 (Dabovic et al., 2015; Noda et al.,
2013). There was an 80% reduction of fibulin-5 mRNA levels in
Ltbp4S−/− and Ltbp4−/− lungs compared to WT lungs (supplementary
material Fig. S6A). Moreover, the normal fibrillar structure of
fibulin-5 was disrupted in the lungs and aortas of both Ltbp-4-
deficient mice and replaced by scattered amorphous patches,
suggesting that there is defective deposition of fibulin-5 into the
ECM (supplementary material Fig. S6B). Ltbp4S−/− fibroblasts
expressed ~50% and Ltbp4−/− ~10% of the normal amount of
fibulin-5 mRNA and protein (supplementary material Fig. S6C,D).
Moreover, fibulin-5 ECM deposition was defective in both
Ltbp4S−/− and Ltbp4−/− lung fibroblasts and similar to the ECM
deposition observed in the corresponding Ltbp-4-deficient tissues
(supplementary material Fig. S6B,E).
Deposition of fibulin-4 on microfibrils requires Ltbp-4L
Previous observations in elastin-producing cell cultures have shown
that fibulin-4 and fibulin-5 are required for tropoelastin deposition
into the ECM (Yamauchi et al., 2010). Although the interaction
between Ltbp-4S and fibulin-5 has recently been shown to be
essential for elastic fiber formation (Noda et al., 2013), functional
interactions between Ltbp-4 and fibulin-4 in this process have not
yet been described. The expression of fibulin-4 declined in lungs
from both Ltbp4S−/− and Ltbp4−/− mice (Fig. 3A). However, fibulin-
4 deposition differed significantly between the knockout strains.
Whereas fibulin-4 deposition into the ECM of Ltbp4S−/− mice was
comparable to that in WT mice, Ltbp4−/− mice exhibited a punctuate
deposition pattern (Fig. 3B). We confirmed the decline of fibulin-4
expression in lung fibroblasts from Ltbp-4-deficient mice
(Fig. 3C,D), whereas only Ltbp4−/− cells showed a defective fibulin-
4 matrix deposition (Fig. 3E). Moreover, to normalize fibulin-4
levels, recombinant full-length fibulin-4 (rfibulin-4) was added to
primary lung fibroblasts. Primary lung fibroblasts from Ltbp4S−/−
and WT mice cultured with rfibulin-4 revealed fibrillar deposition
of the recombinant protein, whereas the deposition of rfibulin-4
appeared scattered and not fibrillar in primary lung fibroblasts from
Ltbp4−/− mice (Fig. 3F), suggesting that at least Ltbp-4L is required
for fibrillar deposition of fibulin-4.
N-terminal regions of Ltbp-4L and Ltbp-4S interact with
fibulin-4
The N-terminal region of Ltbp-4S directly interacts with fibulin-5
(Noda et al., 2013). Based on our data showing that at least Ltbp-
4L is required for fibulin-4 deposition (Fig. 3B,E), we performed
protein-protein interaction studies using N-terminal Ltbp-4L (Ltbp-
4L-2xStrep) and Ltbp-4S (Ltbp-4S-2xStrep) fragments conjugated
to a 2xStrep tag (Fig. 4A) and recombinant full-length fibulin-4 and
fibulin-5 (rfibulin-4 and rfibulin-5). Surface plasmon resonance
analysis revealed that Ltbp-4L-2xStrep and Ltbp-4S-2xStrep interact
with rfibulin-4 and rfibulin-5 (Fig. 4B,C). However, the molecular
dissociation of Ltbp-4L-2xStrep from both rfibulins was
significantly slower than that of Ltbp-4S-2xStrep (supplementary
material Table S2), indicating that the 126 N-terminal amino acids
specific to Ltbp-4L are responsible for a stronger binding affinity of
Ltbp-4L-2xStrep to rfibulin-4 and rfibulin-5.
Ltbp-4 isoform-specific N-glycosylation modulates fibulin
binding
In silico analysis revealed one putative N-glycosylation site within
the specific N-terminal amino acid sequence of Ltbp-4S whereas the
N-terminus of Ltbp-4L was predicted to only be subject to O-linked
glycosylation (Fig. 4A). We verified N-linked glycosylation in a
PNGase F deglycosylation assay with recombinant full-length
human LTBP-4S (Fig. 4D; rLTBP-4S) and also with Ltbp-4S-
2xStrep (Fig. 4E). PNGase F digest of Ltbp-4L-2xStrep showed no
difference in band retardation (Fig. 4E). In order to test whether N-
glycosylation of Ltbp-4L-2xStrep and Ltbp-4S-2xStrep contributes
to rfibulin-4 and rfibulin-5 binding, the PNGase F deglycosylation
assay was also performed under non-denaturating conditions to
enable subsequent surface plasmon resonance analysis (Fig. 4E).
We demonstrated enhanced binding of Ltbp-4S-2xStrep to
rfibulin-4 and rfibulin-5 after deglycosylation with a signal increase
of 15% to 20% whereas binding between Ltbp-4L-2xStrep and
rfibulin-4 or rfibulin-5 was not changed after deglycosylation
(Fig. 4F,G).
DISCUSSION
The human gene involved in ARCL1C was discovered based on the
ultrastructural similarity of elastic fiber defects exhibited in mice
lacking Ltbp-4S (Ltbp4S−/−) and a subcohort of cutis laxa patients
(Sterner-Kock et al., 2002; Urban et al., 2009). However, unlike
ARCL1C patients, Ltbp4S−/− mice live to adulthood despite severe
elastic fiber defects (Sterner-Kock et al., 2002), whereas ARCL1C
patients die very early due to extensive developmental abnormalities
in multiple visceral organs (Urban et al., 2009). These phenotypic
differences are likely due to the inactivation of both LTBP-4
isoforms in ARCL1C patients, which does not occur in Ltbp4S−/−
mice. To test this hypothesis we generated Ltbp4-knockout
(Ltbp4−/−) mice lacking both Ltbp-4 isoforms.
Ltbp4−/− mice grew significantly slower than their WT littermates,
developed dermal and cardiopulmonary abnormalities and died within
2 weeks after birth, most likely due to respiratory failure caused by
extensive pulmonary emphysema similar to that observed in ARCL1C
patients (Table 2) (Callewaert et al., 2013; Urban et al., 2009).
The observed lung, aortic, skin and cardiac phenotype of
Ltbp4S−/− and Ltbp4−/− mice was more severe in the Ltbp4−/− mice
(Table 2), suggesting that Ltbp-4L compensates for some Ltbp-4S
functions. Ltbp-4L functions seem particularly important during
postnatal development and survival to adulthood (Sterner-Kock et
al., 2002). For instance, in the skin, the relatively low Ltbp-4L
expression compared with Ltbp-4S seems to be important for dermal
thickness and density. The distinct tissue expression patterns of
Ltbp-4L in heart and aorta might result from the activation of the
two known Ltbp-4 promoters under the control of independent
transcription factors (Bultmann et al., 2013; Kantola et al., 2010).
Ltbp4−/− mice displayed right ventricular hypertrophy in the heart,
which Ltbp4S−/− mice do not. This could be either a primary
consequence caused by the additional loss of Ltbp-4L or secondary
to increased pulmonary resistance leading to pulmonary
hypertension (Bleeker et al., 2006). The human ARCL1C syndrome
includes pulmonary artery stenosis, pulmonary hypertension, atrial
septal defects, patent foramen ovale, heart valve defects and a mild
right ventricular hypertrophy in one case (Urban et al., 2009). In
contrast to older Ltbp4S−/− mice (Sterner-Kock et al., 2002), no
cardiomyopathy was found in ARCL1C patients, but these
conditions might require a longer time to develop in humans (Urban
et al., 2009).
The disruption of the aortic IEL in mice seems to be dependent
on the expression of Ltbp-4L because we found that only Ltbp4−/−
but not Ltbp4S−/− mice had severely disrupted IEL. Fibulin-2 and
fibulin-5 have been reported to function cooperatively to form the
IEL during postnatal development (Chapman et al., 2010).
Interestingly, Ltbp-4 deficiency leads to upregulation of fibulin-2,
especially in the area of the endothelial lining of the vessel walls in
















the heart (supplementary material Fig. S7). Obviously, this
upregulation of fibulin-2 could protect the IEL only in Ltbp4S−/−
mice, indicating a possible direct or indirect interaction between
Ltbp-4L and fibulin-2. Similar to other models of disturbed
elastogenesis, including elastin (Eln−/−) (Li et al., 1998), fibulin-4
(Fibulin-4−/− and Fibulin-4R/R) (Hanada et al., 2007; McLaughlin et
al., 2006), and lysyl oxidase (Lox−/−) (Mäki et al., 2005) mutant
mice, Ltbp4−/− and to a lesser extent Ltbp4S−/− mice develop thick
aortic walls. Ultrastructural analysis of aortas (data not shown) and
elastic lung arteries (supplementary material Fig. S5) revealed the
presence of amorphous material between elastic fibers in Ltbp4−/−
mice, a phenotype that has already been described in Fibulin-4R/R
mice (Hanada et al., 2007). However, we were not able to
characterize this material in more detail.
Fragmented elastic fibers are the hallmark of LTBP-4 deficiency
in both humans and mice (Sterner-Kock et al., 2002; Urban et al.,
2009). Ltbp4−/− mice and ARCL1C patients (Callewaert et al., 2013;
Urban et al., 2009) show massive elastic fiber fragmentation, which
is significantly less severe in Ltbp4S−/− mice. Formation of
functional elastic fibers requires cross-linking of tropoelastin
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Fig. 3. Ltbp-4L is necessary for fibrillar
matrix deposition of fibulin-4. (A) Fibulin-4
mRNA expression showed significant
downregulation in lungs from Ltbp4S−/− and
Ltbp4−/− mice compared to WT mice (n=4;
*P<0.05). (B) Representative images showing
fibulin-4 immunoreactivity and disruption of the
fibrillar structure of fibulin-4 fibers in aortas
(upper panel) and lungs (lower panel) from
Ltbp4−/− mice compared to WT and Ltbp4S−/−
mice. Scale bars: 20 μm (upper panels), 50 μm
(lower panels). (C) Fibulin-4 mRNA expression
showed significant downregulation in lung
fibroblasts isolated from Ltbp4−/− mice
compared to Ltbp4S−/− and WT mice (n≥5;
**P<0.01). (D) Representative immunoblot of
lung fibroblasts (left) and its densitometric
analysis (right) revealing significant
downregulation of fibulin-4 in Ltbp4S−/− and
Ltbp4−/− mice compared to WT mice (n≥4;
*P<0.05; **P<0.01). Protein as well as mRNA
expression of fibulin-4 of the WT was set to 1.
(E) Representative immunofluorescence
staining of Ltbp-4 and fibulin-4 revealing
reduced expression and disrupted fibrillar
structure of fibulin-4 in primary lung fibroblasts
from Ltbp4−/− mice compared to Ltbp4S−/− and
WT mice. Scale bars: 100 μm.
(F) Representative immunofluorescence
staining revealing fibrillar deposition of
recombinant full-length fibulin-4 (rfibulin-4; 20
nm) in primary lung fibroblasts from Ltbp4S−/−
and WT mice, whereas rfibulin-4 appeared
scattered and not fibrillar in primary lung
fibroblasts from Ltbp4−/− mice. For detection of
rfibulin-4, an anti-strep antibody was used.

















monomers after oxidative deamination by lysyl oxidases and
organization of the insoluble elastin matrix onto a pre-assembled
fibrillin microfibril scaffold (Mithieux and Weiss, 2005; Wagenseil
and Mecham, 2007; Yanagisawa and Davis, 2010). In addition to
structural proteins and cross-linking enzymes, elastic fiber formation
requires multiadhesive adaptor proteins, such as fibulin-4
(Horiguchi et al., 2009; McLaughlin et al., 2006), fibulin-5
(Nakamura et al., 2002; Yanagisawa et al., 2002) and Ltbp-4 (Noda
et al., 2013; Sterner-Kock et al., 2002; Urban et al., 2009), all of
which are present on microfibrils. Fibulin-4 and fibulin-5 have
crucial non-redundant functions in the assembly of elastic fibers
(Papke and Yanagisawa, 2014).
Fibulin-5 mediates coacervation of tropoelastin prior to cross-
linking (Hirai et al., 2007; Wachi et al., 2008) by binding to Ltbp-4S
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Fig. 4. Interaction studies of the Ltbp-4L and Ltbp-4S N-terminal regions with full-length fibulin-4 and fibulin-5. (A) Domain structure of full-length Ltbp-
4L and Ltbp-4S and the recombinantly expressed Ltbp-4L (Ltbp-4L-2xStrep) and Ltbp-4S (Ltbp-4S-2xStrep) N-terminal fragments. The full-length proteins
consist of 4-cystein (4-cys) repeats (white rhombi), non-Ca2+-binding EGF-like repeats (black rectangles), Ca2+-binding EGF-like repeats (white rectangles),
hybrid domains (black ellipses) and 8-cystein (8-cys) repeats (white ellipses). The N-terminal fragments consist of two (Ltbp-4L-2xStrep) or one (Ltbp-4S-
2xStrep) unique 4-cys repeats, the common non-Ca2+-binding EGF-like repeat and a C-terminal 2xStrep tag (red ellipses). Binding sites for ECM proteins,
putative N-glycosylation sites (green lines) as well as the amino acid (aa) lengths are indicated. (B,C) Sensorgrams from surface-plasmon resonance
interaction experiments showed a stronger binding affinity of Ltbp-4L-2xStrep (0-320 nM) ‘flown’ over immobilized recombinant full-length fibulin-5 (B; rfibulin-5)
or immobilized recombinant full-length fibulin-4 (C; rfibulin-4) compared to Ltbp-4S-2xStrep (0-80 nM) flown over immobilized rfibulin-5 (B) or rfibulin-4 (C). The
results are expressed as resonance units (RUs; n=2). (D) Deglycosylation digest with PNGase F of denatured recombinant full-length human LTBP-4S (rLTBP-
4S) showing that there is a shift towards lower molecular mass positions. (E) Upper panel: deglycosylation of Ltbp-4L-2xStrep and Ltbp-4S-2xStrep. Ltbp-4L-
2xStrep was unaffected, whereas Ltbp-4S-2xStrep showed a shift towards lower molecular weight positions. Lower panel: Ltbp-4S-2xStrep was digested with
PNGase F under native (left lanes) and denaturing (right lanes) conditions. Both conditions resulted in a shift towards lower molecular weight positions.
(F,G) After digest under non-denaturing conditions Ltbp-4L-2xStrep and Ltbp-4S-2xStrep were both able to bind to rfibulin-4 and -5 immobilized on a Biacore
chip. Ltbp-4L-2xStrep binding was not affected, whereas Ltbp-4S-2xStrep showed an increase in binding of 15% to 20% after deglycosylation. The continuous
















(Noda et al., 2013), whereas fibulin-4 enhances the binding of
tropoelastin to lysyl oxidase and thus facilitates cross-linking
(Choudhury et al., 2009; Horiguchi et al., 2009). Fibulin-5−/− mice
have severely disorganized elastic fibers throughout the body and
develop severe and progressive elastinopathy postnatally, but survive
to adulthood (Nakamura et al., 2002; Yanagisawa et al., 2002).
Fibulin-4−/− mice fail to form elastic fibers and die perinatally
(Horiguchi et al., 2009; McLaughlin et al., 2006), whereas
hypomorphic Fibulin-4R/R mice can survive up to 14 weeks (Hanada
et al., 2007). This suggests that at least 25% fibulin-4 expression, and
probably its proper deposition, but not fibulin-5, is crucial for
postnatal survival. The expression of fibulin-5 and to a lesser extent
fibulin-4 was repressed in Ltbp4S−/− and Ltbp4−/− mice, suggesting
that Ltbp-4L and Ltbp-4S are required for adequate fibulin-4 and
fibulin-5 expression. The molecular mechanisms leading to fibulin-4
and fibulin-5 repression in Ltbp-4-deficient mice remain to be
investigated. This repression could possibly be mediated by an
outside-in signaling cascade triggered by cellular sensing of an altered
ECM in Ltbp-4-deficient mice.
The fibrillar deposition of fibulin-5 is destroyed in both Ltbp-4-
deficient mouse strains. However, matrix deposition of fibulin-4
appeared to be unaltered in Ltbp4S−/− mice, whereas it was highly
defective in Ltbp4−/− mice, suggesting that Ltbp-4L is important for
this process. The ECM deposition of other ECM proteins, such as
fibronectin and fibrillin-1, was not affected by Ltbp-4 deficiency
(supplementary material Fig. S8). We showed that Ltbp-4L and
Ltbp-4S bind to fibulin-4 and fibulin-5 through their N-termini with
different affinities. The much higher affinity of Ltbp-4L to fibulin-
4 and fibulin-5 might reflect its importance during early postnatal
development when rapid elastic fiber formation is mandatory, for
example, during postnatal lung maturation. A possible mechanism
to modify protein-protein binding is the attachment of
glycosaminoglycan (GAG) chains (Lowery et al., 2014; Torreno-
Pina et al., 2014). We verified the predicted specific N-glycosylation
of Ltbp-4S in vitro and in vivo (supplementary material Fig. S9) and
showed that deglycosylation enhances binding of Ltbp-4S but not
of Ltbp-4L to fibulin-4 and fibulin-5. N-glycosylation patterns can
vary between different tissues and thereby possibly modulate Ltbp-
4S binding to fibulin-4 and fibulin-5. In situations of high
glycosylation of the Ltbp-4S N-terminus, Ltbp-4L-driven binding
mechanisms might be favored. However, another possibility is that
this specific N-glycosylation site is used to enable Ltbp-4S to bind
to additional unknown factors.
Besides their obvious role within the ECM, Ltbp-4L and Ltbp-4S
are reported to modulate the activity of TGFβ by facilitating its
secretion and deposition into the ECM (Annes et al., 2004;
Miyazono and Heldin, 1991). However, TGFβ activity was not
affected in lung fibroblasts of the two Ltbp4-knockout strains
(supplementary material Fig. S10), suggesting that the observed
phenotypes are largely attributable to the loss of Ltbp-4 structural
functions.
Our results suggest that Ltbp-4L and Ltbp-4S orchestrate elastin
deposition onto the ECM fibrillin microfibrils by binding fibulin-4
and fibulin-5, which in turn both target tropoleastin (Choudhury et
al., 2009; Nakamura et al., 2002). In the absence of Ltbp-4S, the
tropoelastin–fibulin-4–fibulin-5 complexes are deposited only
partially onto microfibrils, resulting in an ECM with scattered
fibrillar elastic fibers surrounded by amorphous tropoelastin-fibulin
aggregates. In ECMs produced by cells lacking Ltbp-4L and Ltbp-
4S, fibrillar fibers are non-existent and only amorphous aggregates
are observed, strongly suggesting that both Ltbp-4 isoforms are
required for normal elastogenesis (Fig. 5).
In summary, we characterized a new mouse model for ARCL1C
that will help to elucidate the pathogenesis of this severe disease.
We further showed that Ltbp-4L and Ltbp-4S have important and
partially non-overlapping roles in survival and elastic fiber
formation, and identified fibulin-4 as a new interacting partner of
both Ltbp-4 isoforms. Moreover, we showed that specific N-
glycosylation of Ltbp-4S influences its fibulin-4- and fibulin-5-
binding affinity. Future experiments involving the generation of
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Table 2. Clinical and morphological characteristics of individuals with ARCL1C compared to Ltbp4S–/– and Ltbp4–/– mice
ARCL1C (Callewaert et al., 2013; 
Urban et al., 2009) Ltbp4S−/− (Sterner-Kock et al., 2002) Ltbp4−/−
Lung Respiratory distress; emphysema or At P9: mild emphysema; at 6-8 months: At P9: respiratory distress; severe 
hypoplastic lung severe emphysema with extensive emphysema with extensive atelectatic 
atelectatic areas areas
Skin Cutis laxa At P9: normal dermal thickness and At P9: reduced dermal thickness, increased 
epidermal hydration epidermal hydration
Heart Pulmonary artery stenosis, pulmonary At P9: flattened interventricular septum; At P9: right ventricular hypertrophy and 
hypertension, atrial septal defects, at 6-8 months: cardiomyopathy with flattened interventricular septum
patent foramen ovale, heart valve biventricular dilatation
defects, mild right ventricular 
hypertrophy in one case
Gastrointestinal system Gastro-esophageal reflux, diverticula, At P9: no special findings; >4 weeks: At P9: no special findings; >P9: beginning 
gastric tube, pyloric stenosis, intestinal rectal prolapse rectal prolapse
dilation, tortuosity, umbilical hernia, 
rectal prolapse
Genitourinary system Bladder diverticula, hydronephrosis, At P9: no special findings At P9: no special findings
inguinal hernia
Elastic fibers Severely fragmented elastic fibers At P9: mild to moderately fragmented At P9: severely fragmented elastic fibers
elastic fibers
Fibulin-4 Not determined At P9: reduced expression, fibrillar At P9: reduced expression, scattered and 
deposition no fibrillar deposition
Fibulin-5 Not determined At P9: reduced expression, scattered At P9: reduced expression, scattered and 
and no fibrillar deposition no fibrillar deposition
Growth Postnatal growth delay Normal Postnatal growth delay, reduced lengths of 
long bones

















Ltbp4L- and tissue-specific-Ltbp4-knockout mouse lines are planned
to gain further insights into the isoform-specific functions of 
Ltbp-4.
MATERIALS AND METHODS
Animals, breeding and genotyping
The embryonic stem cell clone E301B04 (E14TG2a.4, 129P2) carrying a
gene-trap insertion in the fifth intron of the Ltbp4 gene (supplementary
material Fig. S1) was purchased from the German Gene Trap Consortium
(GGTC, Helmholtz-Zentrum München, Munich, Germany). These cells
were used to derive chimeric mice that were mated with C57BL/6N female
mice. The offspring was tested for transgene germline transmission and
backcrossed to C57BL/6N background for ten generations. Genotyping of
Ltbp4-knockout mice was performed using 5mL4_gen, 3mL4_gen and
betageo_gen primers (supplementary material Table S3) complementary to
the sequences flanking the gene-trap insertion sites. Generation and
genotyping of Ltbp4S−/− mice was performed as described previously
(Sterner-Kock et al., 2002). Animals were housed in a 12-hour-light-12-
hour-dark cycle and were fed a standard rodent diet (ssniff Spezialdiäten,
Soest, Germany).
Unless otherwise stated, all animals were sacrificed at postnatal day 9 (P9)
by decapitation and autopsies were carried out using standard protocols. For
blood gas analyses (BGA), trunk blood was collected in a heparinised 1.5 ml
tube and pH, pCO2, pO2, sO2, ctHB, Hct, HCO3 and ABE were analyzed
using an ABL800 Flex blood gas analyzer (Radiometer, Willich, Germany).
All animal procedures were performed in accordance with the German Laws
for Animal Protection and were approved by the Institutional Animal Care
and Use Committee: Landesamt für Natur, Umwelt und Verbraucherschutz
Nordrhein-Westfalen (Recklinghausen, Germany).
mRNA expression analysis
Total RNA isolation and real-time PCR were performed as described
previously (Bultmann et al., 2013). All primers and probes are listed in
supplementary material Table S3. Quantification of mRNA levels for Ltbp4,
Ltbp4S and Ltbp4L were calculated using the standard curve method
(Bultmann et al., 2013). Relative expression of tropoelastin, fibulin-5 and
fibulin-4 was adjusted for total RNA content by normalizing to
glyceraldehyde-3-phosphate dehydrogenase (Gapdh) expression.
Calculations were performed by a comparative 2-ΔΔCT method (Livak and
Schmittgen, 2001).
SDS-PAGE and immunoblotting
Protein expression levels were determined by western blotting, using SDS-
PAGE as described previously (Bultmann et al., 2013). All antibodies used
are listed in supplementary material Table S4.
Histology and immunohistochemistry
Mice were sedated with ketamine and xylazine. The heart was punctured
and perfused with PBS and 4% paraformaldehyde according to standard
protocols. Perfusion-fixed aortas, lungs and hearts were dissected and
embedded in paraffin. 4-μm sections were stained with haematoxylin-eosin,
resorcin-fuchsin (elastin) or alcian blue (glucosaminoglycans). For
immunohistochemistry, tissue sections were deparaffinized and antigen
retrieval was performed in 10 mM citrate puffer (pH 6.0) for 20 minutes in
a microwave (Ltbp4, PCNA) or by using proteaseXXIV (DCS Innovative
Diagnostik-Systeme, Hamburg, Germany) for 6 minutes at room
temperature (fibulin-4, fibulin-5) followed by treatment with 3% H2O2 for
15 minutes at room temperature. Incubation with primary antibodies
(supplementary material Table S4) in dilution buffer was performed for 1
hour at room temperature. For detection, Supervision 2-Single Species HRP
Polymer (DCS Innovative Diagnostik-Systeme, Hamburg, Germany) and
Permanet AEC-Kit (ZYTOMED Systems, Berlin, Germany) were used
according to manufacturers’ protocols.
Analyses of skin parameters
The epidermal and dermal thicknesses were determined in skin sections.
Epidermal hydration, transepidermal water loss and net-elasticity of the 
skin were analyzed using the Multi Probe Adapter (MPA) System
(Courage+Khazaka electronic, Cologne, Germany) with the Corneometer
CM 825-, Tewameter TM 300- or Cutometer MPA 580-probe, respectively,
and freshly sacrificed mice according to the manufacturer’s instructions.
Stereological analyses of the cardiac ventricles
The stereological analyses of the cardiac ventricles were determined in
myocardial sections fixed in situ and stained with haematoxylin-eosin as
described previously (Hilfiker-Kleiner et al., 2004; Ricke-Hoch et al.,
2014).
Echocardiography of neonatal mice
High-resolution mouse echocardiography was performed in WT and
Ltbp4−/− mice using a commercially available ultrasound system (Philips
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Fig. 5. Proposed model for the role of Ltbp-4L and Ltbp-4S in elastogenesis. In the presence of Ltbp-4L and Ltbp-4S, microaggregation of tropoelastin,
which is tethered to fibulin-4 and fibulin-5, deposits linearly onto microfibrils. Subsequent coalescence of tropoelastin takes place on microfibrils, resulting in
fibrillar deposition of the tropoelastin–fibulin-4–fibulin-5 complex. In the absence of Ltbp-4S, the tropoelastin–fibulin-4–fibulin-5 complex only partly deposits on
microfibrils, resulting in scattered fibrillar elastic fibers as well as amorphous aggregates of tropoelastin–fibulin-4–fibulin-5, which grow to form globular
structures. In the absence of Ltbp-4L and Ltbp-4S, all tropoelastin–fibulin-4–fibulin-5 complexes form dysmorphous, non-fibrillar globular structures. Modified
















iE33, Philips, Hamburg, Germany) equipped with a 15 MHz linear array
transducer utilizing harmonic imaging (L15-io7, Philips, Hamburg,
Germany). Volumetric analysis of left-ventricular structures was performed
to assess left-ventricular morphology and function (Ghanem et al., 2006;
Zheng-Fischhöfer et al., 2006).
Magnetic resonance imaging of neonatal mice
Magnetic resonance imaging (MRI) studies were performed in two mice per
genotype using a clinical 3 Tesla MR whole-body system (Achieva 2.3,
Philips, Best, The Netherlands) as described previously (Bunck et al., 2009).
For optimal MR signal detection, a dedicated solenoid receive-only coil was
used (Philips, Forschungslaboratorien, Aachen, Germany). After positioning
of the mouse in the isocenter of the magnet gradient, echo scout images were
acquired in a horizontal orientation for localization of the heart. For cine
imaging, we used a retrospectively ECG-triggered, segmented gradient echo
sequence. The number of signal averages was set to eight to achieve good
signal-to-noise ratios. The reconstructed in-plane spatial resolution was
0.13×0.13 mm; slice thickness was set to 0.8 mm. Per heart cycle, 30 phases
were imaged. For left-ventricular assessment, standard imaging planes were
obtained according to the recommendations by Schneider et al. (Schneider
et al., 2006).
Electron microscopy
For transmission electron microscopy, organ tissues were fixed in 5%
glutaraldehyde in 0.4 M PBS buffer (pH 7.2-7.3). The samples were washed
three times with 0.1 M cacodylate buffer and stored in this buffer at 4°C
until plastic embedding. Afterwards preparations were postfixed with 2%
osmium tetraoxide in 0.1 M cacodylate buffer for 2 hours at 4°C. Before
embedding in araldite (Novartis Pharma, Nürnberg, Germany) the specimens
were dehydrated in a graded series of ethanol. Sections of plastic-embedded
specimens were cut with a diamond knife for thin sections and ultrathin
sections on an ultra-microtome (Reichert, Buffalo, NY, USA). The 0.5-μm
thin slices were stained with Methylene Blue and examined using a Zeiss
Axiovert 200 (Zeiss, Oberkochen, Germany). Ultrathin sections (60 nm)
were mounted on formvar-coated copper grids, stained with 0.2% uranyl
acetate and lead citrate and then examined with a Zeiss EM 902 A electron
microscope (Zeiss, Oberkochen, Germany).
Isolation of elastin, and quantification of desmosine and
isodesmosine
Pure elastin, free of contaminants by other ECM components, was isolated
from biopsies of mouse lung as described previously (Schmelzer et al.,
2012). Isolated elastin samples were weighed and then hydrolyzed at a
concentration of 1 mg/ml in 6 M HCl at 105°C for 24 hours, respectively,
to allow the liberation of DES and IDES. After incubation, the samples
were evaporated to dryness at 60°C, and the residues were taken up in
acetonitrile:water (1:1, v/v) prior to liquid chromatography mass
spectrometry (LC-MS) analysis. LC-MS analysis of DES and IDES was
carried out using an Agilent 1100 LC system (Agilent Technologies,
Waldbronn, Germany) coupled to a quadrupole ion trap mass spectrometer
Finnigan LCQ (Thermo Fisher Scientific, Waltham, MA) by an
electrospray interface. Isocratic chromatographic separation was
performed over 8 minutes at a flow rate of 0.2 ml/min on a Reprosil-Pur
120 C18 AQ 3 μm column (150×2 mm, Maisch, Ammerbuch-Entringen,
Germany). 0.1% formic acid/methanol (97.5:2.5, v/v) was used as the
mobile phase and the column temperature was 40°C. Under these
chromatographic conditions DES and IDES co-elute. For mass
spectrometric analyses, the following parameters were used: positive 
ion mode, electrospray voltage: 4.5 kV, heated capillary temperature:
220°C.
Isolation of primary lung fibroblasts
Mouse lung fibroblasts were isolated according to described protocols
(Seluanov et al., 2010). In brief, tissues were finely chopped, and digested
with 0.12 Wünsch units/ml Liberase TM research Grade (Roche
Diagnostics, Mannheim, Germany) for 30 minutes at 37°C. Cells were
outgrown in DMEM/F12 (Gibco, Life Technologies, Darmstadt, Germany)
containing 15% FCS (Biochrom, Berlin, Germany) and antibiotic/
antimycotic (Life Technologies, Darmstadt, Germany) at 37°C in 5% CO2.
After the first passage, remaining tissue fragments were discarded and cells
were incubated in EMEM (Gibco, Life Technologies, Darmstadt, Germany)
containing 15% FCS and penicillin-streptomycin (Life Technologies,
Darmstadt, Germany).
Expression of recombinant proteins and deglycosylation assay
Full-length rLTBP-4S was purified as previously described (Noda et al.,
2013). The first 253 amino acids of mouse Ltbp-4L (Ser25-Asp277) and the
first 185 amino acids of mouse Ltbp-4S (Arg27-Asp211) after the signal
peptide, as well as mouse full-length fibulin-4 and fibulin-5 after the signal
peptide, were cloned into a modified pCEP-Pu vector containing a 3ʹ
2xStrepII tag using the restriction sites NheI and XhoI, and stably expressed
in human embryonic kidney (HEK) 293 EBNA cells. The Strep-tagged
proteins were purified from conditioned medium. Collected supernatants
were supplemented with 1 mM phenylmethylsulfonyl fluoride, filtered and
passed over a streptactin-Sepharose column. The recombinant proteins were
eluted with elution buffer (100 mM Tris-HCl pH 7.4, 150 mM NaCl)
containing 2.5 mM d-desthiobiotin.
Deglycosylation of denatured rLTBP-4S (200 ng) or homogenized WT
lung (20 μg) was performed using 250 units recombinant PNGase F (New
England Biolabs, Frankfurt am Main, Germany) for 3 hours at 37°C, or of
native or denatured Ltbp-4L-2xStrep and Ltbp-4S-2xStrep (10 μg) using 500
units of PNGase F for 48 hours at 37°C according to the manufacturer’s
protocol.
Immunofluorescence analysis
Primary lung fibroblasts were seeded on glass coverslips and cultured for 7
days in EMEM, 15% FCS and penicillin-streptomycin with or without
recombinant full-length fibulin-4 (20 nm). Cells were fixed in methanol or
PFA for 20 minutes at −20°C, and blocked with 5% BSA in PBS for 1 hour
at room temperature. Cells were incubated with primary antibodies
(supplementary material Table S4) in 1% BSA overnight at 4°C. Secondary
antibodies were coupled to Alexa-Fluor-488 donkey anti-rabbit IgG, or
Alexa-Fluor-546 donkey anti-goat IgG (Life Technologies, Darmstadt,
Germany). Nuclei were counterstained with DAPI (Life Technologies,
Darmstadt, Germany). Images were taken using a confocal LSM710
microscope (Zeiss, Oberkochen, Germany).
Surface plasmon resonance
Binding analyses were performed by using a BIAcore2000 (GE Healthcare
GmbH, Solingen, Germany). 570 RUs of rfibulin-4, and 390 RUs of
rfibulin-5 were covalently coupled to carboxymethyldextran hydrogel 500M
sensor chips (XanTec, Düsseldorf, Germany) using the amine coupling kit
following the manufacturer’s instructions (GE Healthcare, Solingen,
Germany). Interactions between Ltbp-4L-2xStrep or Ltbp-4S-2xStrep and
rfibulin-4 and rfibulin-5 were performed as previously described (Sengle et
al., 2008). For determination of the kinetic constants, each individual
sensorgram was fitted using the BIAevaluation 4.1 software (1:1 Langmuir
interaction model) according to the manufacturer’s instructions. The
determined pseudo-first order kinetic constants kobs were plotted versus the
analyte concentrations and a linear best fit was applied. The average koff
equals the intersection with the y-axis. The slope of the fitted straight line is
a measure of the kon rate. Apparent equilibrium dissociation constants (Kd)
were then calculated as the ratio of koff to kon.
TGFβ activity bioassay
TGFβ levels were assessed in 48-hour conditioned medium of primary lung
fibroblasts that were cultured in DMEM (2% FCS, 1% penicillin-
streptomycin, 10% BSA). TGFβ activity was determined by using a
plasminogen activator inhibitor-1 (PAI-1) promoter luciferase reporter assay
(Abe et al., 1994) using mink lung epithelial cells stably expressing the
firefly luciferase reporter gene under the control of a TGFβ-specific,
truncated PAI-1 promoter.
Active TGFβ was determined after overnight incubation of the reporter
cells with conditioned medium or with recombinant human TGFβ1
413

















standards. The reporter cells were lysed and luciferase activity was measured
using the Beetle-Juice kit (PJK, Kleinblittersdorf, Germany) and a GloMax-
Multi Detection System (Promega, Mannheim, Germany).
Statistical evaluation
Data are presented as a mean±s.d. Differences between groups were
analyzed by Mann-Whitney test, log-rank test, Student’s t-test or ANOVA,
followed by Bonferroni correction as appropriate. Statistical significance of
post-hoc analyses was taken at P<0.05. Calculations were performed using
SPSS21 (IBM Deutschland, Ehningen, Germany).
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